4//SEC Filing
Dananberg Jamie 4
Accession 0000899243-22-036543
CIK 0001463361other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:35 PM ET
Size
5.7 KB
Accession
0000899243-22-036543
Insider Transaction Report
Form 4
Dananberg Jamie
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-11-18+65,000→ 65,000 totalExercise: $2.38Exp: 2032-11-18→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The underlying shares vest and become exercisable pursuant to the following schedule: One-eighth of the shares subject to the option vest in successive, equal quarterly installments starting on February 18, 2023, subject to the Reporting Person's continued service to Issuer through the applicable vesting date.
Documents
Issuer
Unity Biotechnology, Inc.
CIK 0001463361
Entity typeother
Related Parties
1- filerCIK 0001734424
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:35 PM ET
- Size
- 5.7 KB